Panelists acknowledge difficulty generating stronger data in ultra-rare disease
Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease
Only a minority of patients adhered to SUNTRAC screening recommendations
Recent developments of interest in cardiovascular medicine
Ratings look like noise due to volatile score changes every half year
Also in TTHealthWatch: diagnosing Parkinson's with a skin biopsy